Skip to content

The sequential embryo transfer compared to single embryo transfer in one cycle

The sequential embryo transfer in the third and fifth day compared to single embryo transfer in the fifth day in IVF cycle

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141217020351N10
Enrollment
130
Registered
2018-05-13
Start date
2015-04-09
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility,Repeated implantation failure,?Embryo transfer,Blastocyst. Female infertility

Interventions

Intervention 1: Intervention group: patients were randomized to one of the 2 groups of Intervention and control .After ovulation induction, ?When 3leading follicles reached more than 17 mm diameter m

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: age = 40 years normal karyotype normal screening of immunological and thrombolytic condition the absence of endometrial abnormalities by hysteroscopy availability of =5 embryos

Exclusion criteria

Exclusion criteria: potential poor responders Ovarian hyper stimulation response presence of medical diseases

Design outcomes

Primary

MeasureTime frame
Chemical pregnancy. Timepoint: Two weeks after the stopping the menstruation. Method of measurement: Blood sample for B-HCG.;Clinical Pregnancy. Timepoint: Six weeks after seeing the embryo sac in ultrasound. Method of measurement: Ultrasonography.

Secondary

MeasureTime frame
Abortion. Timepoint: After positive pregnancy test. Method of measurement: Blood sample of B-HCG.;Ectopic pregnancy. Timepoint: After the positive of pregnancy test. Method of measurement: Sonography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEnsieh Shahrokh Tehraninejad

Tehran University of Medical Sciences

etehraninejad@sina.tums.ac.ir+98 21 6658 1616

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026